14 completed. 14 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 14 |
| Phase 2 | 1 | Completed 1 |
Follow Chronic Myeloproliferative Disorders: new trials by email Literature Review of Chronic Myeloproliferative Disorders trials Research Report on Chronic Myeloproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| American Ginseng in Treating Patients With Fatigue Caused by Cancer American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 364 | 2008-10-01 | 2017-02-09 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder cyclosporine ophthalmic emulsion, placebo - Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 3 | Completed | Vanderbilt-Ingram Cancer Center | 164 | 2008-10-01 | 2017-03-07 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families educational intervention, informational intervention, internet-based intervention - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Tufts Medical Center | 198 | 2008-06-01 | 2011-07-13 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Case Comprehensive Cancer Center | 583 | 2008-04-01 | 2020-07-27 |
| Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer baclofen/amitriptyline/ketamine gel, placebo - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 208 | 2008-02-01 | 2017-08-24 |
| Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases filgrastim, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation - Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 3 | Completed | The Canadian Blood and Marrow Transplant Group | 230 | 2007-03-01 | 2014-03-05 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Vanderbilt-Ingram Cancer Center | 98 | 2005-05-01 | 2012-09-06 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 100 | 2000-10-01 | 2016-07-06 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Fragmin, placebo - Cervical Cancer, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Jonsson Comprehensive Cancer Center | 2000-04-01 | 2020-08-03 | |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer St. John's wort - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 1999-12-01 | 2013-01-18 | |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy epoetin alfa, placebo - Anemia, Breast Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 344 | 1998-12-01 | 2016-07-13 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer anti-thymocyte globulin, busulfan, carboplatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 2 / Phase 3 | Completed | Roswell Park Cancer Institute | 361 | 1998-10-19 | 2021-08-13 |
| Treatment for Chronic Pain in Patients With Advanced Cancer dextromethorphan hydrobromide, morphine sulfate - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | NCIC Clinical Trials Group | 87 | 1998-06-11 | 2020-04-03 |
| Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer amphotericin B deoxycholate, nystatin - Chronic Myeloproliferative Disorders, Infection | Phase 3 | Completed | Aronex Pharmaceuticals | 1996-01-01 | 2013-03-26 |
Leukemia (14) · Lymphoma (14) · Myeloproliferative Disorders (14) · Myelodysplastic Syndromes (13) · Burkitt Lymphoma (11) · Leukemia, Myeloid, Accelerated Phase (11) · Leukemia, Myeloid, Chronic-Phase (11) · Lymphoma, Non-Hodgkin (11) · Multiple Myeloma (11) · Neoplasms, Plasma Cell (11) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (11) · Primary Myelofibrosis (11) · Blast Crisis (10) · Hodgkin Disease (10) · Leukemia, Lymphocytic, Chronic, B-Cell (10)
Bone Marrow Diseases (14) · Hematologic Diseases (14) · Hemic and Lymphatic Diseases (14) · Immune System Diseases (14) · Immunoproliferative Disorders (14) · Lymphatic Diseases (14) · Neoplasms by Histologic Type (14) · Blood Protein Disorders (13) · Cardiovascular Diseases (13) · Hemorrhagic Disorders (13) · Hemostatic Disorders (13) · Neoplasms (13) · Paraproteinemias (13) · Vascular Diseases (13) · Pathological Conditions, Signs and Symptoms (12)
Early Intervention, Educational (3) · Antilymphocyte Serum (1) · Asian ginseng (1) · Baclofen (1) · Busulfan (1) · Carboplatin (1) · Cyclophosphamide (1) · Cyclosporins (1) · Dalteparin (1) · Dextromethorphan (1) · Epoetin Alfa (1) · Etoposide (1) · Filgrastim (1) · Hypericum extract LI 160 (1) · Melphalan (1)
Alliance for Clinical Trials in Oncology (4) · Vanderbilt-Ingram Cancer Center (2) · Aronex Pharmaceuticals (1) · Case Comprehensive Cancer Center (1) · Jonsson Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · NCIC Clinical Trials Group (1) · Roswell Park Cancer Institute (1) · The Canadian Blood and Marrow Transplant Group (1) · Tufts Medical Center (1)
United States (13) · Canada (3) · Australia (1) · New Zealand (1) · Saudi Arabia (1)
Debra Barton, RN, PhD, AOCN, FAAN (2) · David J. Straus, MD (1) · David S. Gordon, MD (1) · Eduardo Bruera, MD (1) · Jeffrey H. Lipton, MD, PhD (1) · John A. Glaspy, MD, MPH (1) · Madan Jagasia, MD (1) · Nancy Wells, DNSc, RN (1) · Neal J. Meropol, MD (1) · Philip L. McCarthy, MD (1) · Stephen Couban, MD (1) · Steven R. Alberts, MD (1) · Susan K. Parsons, MD, MRP (1) · Thomas E. Witzig, MD (1)
PMID 17397698, PMID 20496177, PMID 21479990, PMID 22157574, PMID 26700120, PMID 26700123, PMID 28935847, PMID 36999619
P30CA068485 (2), R01CA119196 (1), R01CA127655 (1)